Navigation Links
BIOSAFE Labs and Glycemion to Provide Free Diabetes Risk Assessment Kits to U.S. School Children
Date:2/5/2008

LAKE FOREST, Ill., Feb. 5 /PRNewswire/ -- BIOSAFE Laboratories, Inc., the developer of the BIOSAFE Diabetes Risk Assessment, and Glycemion, the United States distributor, have announced the availability of a limited number of test kits for use in schools to help identify diabetic and pre-diabetic children and adolescents. The BIOSAFE Diabetes Risk Assessment is a two-part process comprised of an immediate fasting glucose reading and a mail-in laboratory analysis for hemoglobin A1c, a blood glucose marker for the previous ninety-day period. Samples for both tests can be either professionally collected or self-collected through the use of a simple finger-nick collection kit. Taken in combination, these two results become a reliable indicator of diabetes or a pre-diabetes condition.

Type 2 diabetes (non-insulin dependent diabetes) affects more than 20 million Americans and is the most common form of the disease. However, because diabetes exhibits few if any symptoms until its advanced stages, millions more are in eminent danger of developing the disease and are unaware of it. When blood glucose (sugar) levels are higher than normal, but not yet high enough to be classified as diabetes, a condition known as pre-diabetes exists. If discovered early, a person with pre-diabetes can avoid the devastating complications of diabetes through education, diet, exercise, and appropriately prescribed medications.

"Diabetes is a debilitating, crippling, and life-shortening disease whose most serious complications like blindness, heart disease and kidney failure can often be prevented with early detection. Current trends show that the incidence of diabetes is increasing among children and adolescents. For this reason we are pleased to make the BIOSAFE Diabetes Risk Assessment available to school age children to assist in the early identification of diabetes and pre-diabetes," said Jack Maggiore, PhD, president of BIOSAFE Laboratories, Inc. "Despite decades of med
'/>"/>

SOURCE BIOSAFE Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Leading Network of Aesthetic Service Providers Offers Unique Gift Ideas for Valentines Day
2. FTC Opposes Collective Bargaining for Providers in Puerto Rico
3. Providence Service Corporation to Present at the 2008 UBS Global Healthcare Services Conference on February 11
4. Anti-parasite drug may provide new way to attack HIV
5. Laser Energetics Provides Joint Venture Update to Shareholders
6. Health Care Solutions Provider Payformance Health Standardizes on PGP Encryption for Data Security
7. ATS Medical Provides Update on First Generation Tissue Valve Approval
8. Survey: Two-thirds of Illinois public schools provide comprehensive sex education
9. OxySure(R) Systems, Inc. Named to 2008 Worlds Best Technologies (WBT) List For its Unique, Safe and Easy to Use Portable Emergency Oxygen Generator, Which Provides Medical Oxygen Without the Need for Compressed Tanks
10. Life:WIRE(TM) to Provide Action Healthcare Management with Innovative Mobile Health Management Solution for Patients with Chronic Conditions
11. NightHawk Radiology exclusive radiology provider for high-risk plaque research initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
...ectually disabled Australians will soon enjoy bett...new Medicare rebate created// at the AMA’s urging,...group, people with an intellectual disability have...any Australians, mostly because they can find it d...
... with mesothelioma — a form of cancer associated w...e when treated with a combination// of two cancer ...ma, a rare but aggressive form of cancer that occu...gs, heart and abdomen, is associated with exposure...
... A botched up family planning operation would have...ing British doctor of Indian origin// wasn't there...ctor Ashok Vardhan's visit to Purnea district, 300...ti Devi, who was comatose after a portion of her l...
...ientists have come out strongly against the NHS's ...r to those in the age group 25 to 29, leaving// o...e doctors, Consultant cytopathologists Amanda Herb...dation Trust in London, and John Smith, from the R...
Other Medicine News:Health News:Chemo Combination Improves Survival in Asbestos-Related Cancer 2Health News:Chemo Combination Improves Survival in Asbestos-Related Cancer 3Health News:Extend Cervical Smears to Younger Women, Insist Specialists 2
(Date:9/4/2008)...Patient Identification for Targeted Therapies ...tment HUNTINGTON BEACH, Calif., and AMSTERDAM, ...rld leader in molecular cancer diagnostics,today ...nostic test that,allows physicians to quantitative...rogen receptor (ER), progesterone receptor (PR) an...
(Date:9/3/2008)...t. 3 /- Simcere,Pharmaceuti...d supplier of,branded generic pharmaceuticals and ...roduct Endu (also known as Endostar) in China,ann...al study., At the request of the SFDA, Simcere in...ate the safety and therapeutic efficacy of Endu, a...
(Date:9/3/2008)...nd GENEVA, Sept. 3 /- Artelis SA and,...based monoclonal antibody,production with the achi...er liter. This record level was accomplished by ap...igh-performance stable Selexis CHO,production cell...ists at,Selexis SA using their proprietary Selexis...
(Date:9/3/2008)...rations, Updates Zingo Launch Progress and Adlea ... Conference Call Today at 11:30 am ET, ...FirstCall/ -- Anesiva,Inc. (Nasdaq: ANSV ) annou...tions to focus on commercial and late-stage produc...ecialty pharmaceutical pain management,company. Th...
Breaking Medicine Technology:Agendia Launches TargetPrint(R) for Breast Cancer Patients 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 2Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 2Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 5Singapore Is One of the Fastest Growing Bioclusters in Asia 3B Wave of Investments in Drug Discovery and Translational Research 22083 1Singapore Is One of the Fastest Growing Bioclusters in Asia 3B Wave of Investments in Drug Discovery and Translational Research 22083 2Singapore Is One of the Fastest Growing Bioclusters in Asia 3B Wave of Investments in Drug Discovery and Translational Research 22083 3Singapore Is One of the Fastest Growing Bioclusters in Asia 3B Wave of Investments in Drug Discovery and Translational Research 22083 4Singapore Is One of the Fastest Growing Bioclusters in Asia 3B Wave of Investments in Drug Discovery and Translational Research 22083 5Singapore Is One of the Fastest Growing Bioclusters in Asia 3B Wave of Investments in Drug Discovery and Translational Research 22083 6150 Years Later House Divided Speech Still Holds Strong Message 22081 1150 Years Later House Divided Speech Still Holds Strong Message 22081 2AHIP Selects HealthTrio to Join AHIP Solutions Program 22079 1AHIP Selects HealthTrio to Join AHIP Solutions Program 22079 2Gentiva 28R 29 Health Services to Present June 24 at Jefferies 2nd Annual Healthcare Conference in New York 22077 1Gentiva 28R 29 Health Services to Present June 24 at Jefferies 2nd Annual Healthcare Conference in New York 22077 2Gentiva 28R 29 Health Services to Present June 24 at Jefferies 2nd Annual Healthcare Conference in New York 22077 3
...- Cytogen,Corporation (NASDAQ: CYTO) reported upda...uating QUADRAMET(R) (samarium Sm-153,lexidronam in...),Millennium Pharmaceuticals, Inc.) in patients w...ts were presented today in a,poster titled, "Phase... Multiple Myeloma," by James Berenson, M.D., Medic...
...tion against,infection with virus types beyond 16 ...ine, PHILADELPHIA, June 27, 2007 /PRNewswire-First...se III study show that,CERVARIX(R), the GlaxoSmith...up to 100 percent protection against advanced prec...f human papillomavirus,types 16 and 18. The study...
Other Medicine Technology:Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 2Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 3Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 4Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 5Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 6Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 7Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 8Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 2Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 3Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 4Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 5Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 6Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 7
...ment introduction. The design of the introducer fe...ition profile between the introducer sheath and in...h fascial tissue and strictured areas. Proximal re...ducer sheath and introducer dilator during sheath ...
Used for catheter or instrument introduction. The dual knobs allow the sheath to be peeled away and removed. The maximum diameter of the catheter or instrument to be introduced should be measured to
Used to establish a percutaneous tract into the renal pelvis for catheter placement or stone manipulation. Supplied sterile in peel-open packages. Intended for one-time use.
Used for antegrade placement of a safety wire guide prior to endourological procedures. Supplied sterile in peel-open packages. Intended for one-time use.
Medicine Products: